| Product Code: ETC9508045 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Suriname import of chemiluminescence immunoassay (CLIA) analyzers in 2024 continued to be dominated by top exporters such as the United States, China, Netherlands, Trinidad and Tobago, and Taiwan. Despite a significant decrease in the HHI concentration from very high in 2023 to high in 2024, the negative CAGR of -16.08% indicates a declining trend in import volumes over the period 2020-2024. The steep drop in growth rate from 2023 to 2024 at -45.44% suggests a challenging market environment for CLIA analyzer imports in Suriname.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market - Industry Life Cycle |
3.4 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market - Porter's Five Forces |
3.5 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Suriname |
4.2.2 Growing adoption of advanced diagnostic technologies |
4.2.3 Rising healthcare expenditure and focus on improving healthcare infrastructure |
4.3 Market Restraints |
4.3.1 High initial setup costs for establishing clia analyzer facilities |
4.3.2 Lack of skilled professionals to operate and maintain clia analyzers in Suriname |
4.3.3 Limited awareness and accessibility of clia analyzer technology in remote areas |
5 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market Trends |
6 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market, By Types |
6.1 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenues & Volume, By Analyzers, 2021- 2031F |
6.1.4 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenues & Volume, By Reagents, 2021- 2031F |
6.1.5 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenues & Volume, By Consumables, 2021- 2031F |
6.2 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenues & Volume, By Endocrine Disorders, 2021- 2031F |
6.2.3 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.4 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.5 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenues & Volume, By Hepatitis and Retrovirus, 2021- 2031F |
6.2.6 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenues & Volume, By Cardiovascular Disorders, 2021- 2031F |
6.2.7 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenues & Volume, By Allergy, 2021- 2031F |
6.2.8 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenues & Volume, By Others, 2021- 2031F |
6.2.9 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenues & Volume, By Clinical Laboratories, 2021- 2031F |
6.3.4 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenues & Volume, By Pharmaceutical & Biotechnology Industries, 2021- 2031F |
6.3.5 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenues & Volume, By Others, 2021- 2031F |
7 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market Import-Export Trade Statistics |
7.1 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market Export to Major Countries |
7.2 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market Imports from Major Countries |
8 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market Key Performance Indicators |
8.1 Average turnaround time for test results |
8.2 Rate of adoption of clia analyzers in healthcare facilities |
8.3 Number of research studies and publications utilizing clia analyzers in Suriname |
9 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market - Opportunity Assessment |
9.1 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market - Competitive Landscape |
10.1 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenue Share, By Companies, 2024 |
10.2 Suriname Chemiluminescence Immunoassay (CLIA) Analyzers Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |